Abstract：
This Viewpoint discusses the controversy over mail-order mifepristone prescribed by primary care clinicians for first-trimester abortion as it relates to the history of initial approval, the Supreme Court case Alliance for Hippocratic Medicine v US Food and Drug Administration, and available clinical research.
摘要：
本观点讨论了初级保健临床医生为妊娠早期流产开出的邮购米非司酮的争议，因为它与最初批准的历史有关。最高法院案件希波克拉底医学联盟诉美国食品和药物管理局，和可用的临床研究。
